Skip to main content
Top
Published in: Supportive Care in Cancer 5/2024

01-05-2024 | Radiotherapy | Research

Perceived control, self-management efficacy, and quality of life in patients treated with radiation therapy for breast cancer: a longitudinal study

Authors: Hai-mei Qu, Hong-yue Zhong, Tian Xiao, Yan-jun Li, Pan Ren, Xiao-ju Chen

Published in: Supportive Care in Cancer | Issue 5/2024

Login to get access

Abstract

Objective

This longitudinal study aims to examine the present state of perceived control, self-management efficacy, and overall quality of life (QoL) in patients with breast cancer undergoing radiotherapy, and gain insight into the dynamic trends and factors that influence the quality of life experienced by patients during the course of radiotherapy.

Methods

Participants completed the Cancer Experience and Efficacy Scale (CEES), Strategies Used by People to Promote Health (SUPPH), and Functional Assessment of Cancer Therapy- Breast (FACT-B). The data was analyzed using the software SPSS26.0. Repeated measures analysis of variance (ANOVA) and mixed-effects linear models were used to analyze trends in perceived control, self-management efficacy, and QoL at three-time points, as well as factors affecting QoL during radiotherapy.

Results

Perceived control and self-management efficacy were associated with QoL over the course of the radiotherapy. Self-management efficacy (β = 0.30, P < 0.001), presence of chemotherapy (β = 18.33, P = 0.024), and duration of illness (β = 2.25, P = 0.028) had a positive effect on the change in QoL, while time (β =  − 2.95, P < 0.001), cancer experience (β =  − 0.46, P < 0.001), and type of medical insurance (β =  − 2.77, P = 0.021) had the negative effect on the change in QoL.

Conclusion

The QoL, perceived control, and self-efficacy of patients with breast cancer show dynamic changes during radiotherapy. The higher the self-efficacy, the better the QoL, and the worse the QoL when the sense of disease control is poor. At the same time, more attention should be paid to the QoL of breast cancer radiotherapy patients with a long course of the disease, receiving chemotherapy, and different medical payment methods.
Appendix
Available only for authorised users
Literature
2.
go back to reference Shutko AN, Akushevich IV, Ekimova LP et al (2013) The mechanism of the antitumor effect of total/subtotal radiotherapy with non-tumoricidal doses of radiation. Vopr Onkol 59:475–478PubMed Shutko AN, Akushevich IV, Ekimova LP et al (2013) The mechanism of the antitumor effect of total/subtotal radiotherapy with non-tumoricidal doses of radiation. Vopr Onkol 59:475–478PubMed
3.
12.
go back to reference Wallston KA, Wallston BS, Smith S et al (1987) Perceived control and health. Curr Psychol 6:5–25CrossRef Wallston KA, Wallston BS, Smith S et al (1987) Perceived control and health. Curr Psychol 6:5–25CrossRef
19.
go back to reference Wang Z, Wang B (2020) Research on basic theories and statistical methods of biostatistics—review of statistical methods of biomedical research (2nd edition). China Meas Test 46(12):169 Wang Z, Wang B (2020) Research on basic theories and statistical methods of biostatistics—review of statistical methods of biomedical research (2nd edition). China Meas Test 46(12):169
25.
go back to reference Liu B, Xiao Q (2020) The status quo and influencing factors of perceptual control in breast cancer patients. Hebei Med 42:1743–1746 Liu B, Xiao Q (2020) The status quo and influencing factors of perceptual control in breast cancer patients. Hebei Med 42:1743–1746
Metadata
Title
Perceived control, self-management efficacy, and quality of life in patients treated with radiation therapy for breast cancer: a longitudinal study
Authors
Hai-mei Qu
Hong-yue Zhong
Tian Xiao
Yan-jun Li
Pan Ren
Xiao-ju Chen
Publication date
01-05-2024
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 5/2024
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-024-08485-4

Other articles of this Issue 5/2024

Supportive Care in Cancer 5/2024 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine